|
Market Closed -
Other stock markets
|
Pre-market 08:13:32 | |||
| 10.44 EUR | -6.12% |
|
9.495 | -9.05% |
| 06-24 | Oddo BHF Still Positive on Genfit |  |
| 06-24 | Genfit's Investigative Treatment for Bile Duct Cancer Shows Positive Results in Phase 1b Study | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 46.36B | |||||
| 37.88B | - | - | - | - | - |
| 31.12B | |||||
| 30.61B | |||||
| 24.69B |
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Charts GENFIT
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
